Healthcare Triangle Sets 1-for-20 Reverse Split to Regain Nasdaq Compliance
HCTI sits 15% above its 52-week low of $0.36 on light trading volume (0.1× avg).
Summary
Healthcare Triangle will execute a 1-for-20 reverse stock split, effective Oct. 26 at 12:01 a.m. ET, as part of its plan to regain compliance with Nasdaq's $1.00 minimum bid price rule. The common stock will commence trading on a post-split basis at market open on Oct. 26 and will continue to trade on Nasdaq under its existing trading symbol. The ratio is tighter than the up-to-1-for-25 authorization shareholders were asked to approve at the October 23 special meeting, and it follows the October 2 Staff Delisting Determination against the company. The split mechanically lifts the share price above the $1.00 threshold but does nothing for the underlying business: Q2 revenue was $9.2M with a $4.4M net loss and only $1.9M of cash. The same proxy also sought approval for a $100M dilutive issuance authorization, so the compliance fix comes alongside substantial potential dilution. Watch the October 23 shareholder vote and any Nasdaq hearing or extension decision on the delisting appeal.
Updates
· Seeking Alpha — The 1-for-20 reverse split cuts outstanding shares from about 17.73M to 886,501; HCTI slipped about 5% in Thursday premarket trading.
At the time of this announcement, HCTI was trading at $0.42 on NASDAQ in the Technology sector, with a market capitalization of approximately $7.4M. The 52-week trading range was $0.36 to $188.40. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.